Shares of Sientra, Inc. (NASDAQ:SIEN) have received an average rating of “Hold” from the seven analysts that are currently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $13.75.

SIEN has been the topic of a number of analyst reports. Lake Street Capital reaffirmed a “buy” rating and set a $15.00 price objective (up from $11.00) on shares of Sientra in a research report on Wednesday, August 2nd. Canaccord Genuity initiated coverage on Sientra in a research report on Monday, August 28th. They set a “buy” rating and a $14.00 price objective on the stock. Zacks Investment Research raised Sientra from a “sell” rating to a “hold” rating in a research report on Wednesday, July 12th. Stephens initiated coverage on Sientra in a research report on Tuesday, July 11th. They set an “overweight” rating and a $12.00 price objective on the stock. Finally, ValuEngine raised Sientra from a “sell” rating to a “hold” rating in a research report on Thursday, June 22nd.

TRADEMARK VIOLATION WARNING: This article was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this article on another publication, it was illegally copied and reposted in violation of international copyright and trademark legislation. The original version of this article can be read at https://www.watchlistnews.com/sientra-inc-sien-receives-consensus-recommendation-of-hold-from-brokerages/1617127.html.

Shares of Sientra (NASDAQ:SIEN) opened at 15.93 on Friday. The company’s market capitalization is $307.54 million. Sientra has a 12 month low of $6.92 and a 12 month high of $16.49. The stock’s 50 day moving average price is $13.40 and its 200 day moving average price is $10.08.

Sientra (NASDAQ:SIEN) last posted its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported ($0.55) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.59) by $0.04. Sientra had a negative return on equity of 52.30% and a negative net margin of 173.83%. The firm had revenue of $8.20 million for the quarter, compared to analysts’ expectations of $6.97 million. The firm’s revenue was up 32.3% on a year-over-year basis. On average, analysts forecast that Sientra will post ($2.94) EPS for the current year.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Paulson & CO. Inc. bought a new stake in Sientra during the 2nd quarter valued at approximately $776,000. California State Teachers Retirement System bought a new stake in Sientra during the 2nd quarter valued at approximately $246,000. State Street Corp bought a new stake in Sientra during the 2nd quarter valued at approximately $1,449,000. Cloverdale Capital Management LLC raised its stake in Sientra by 28.9% during the 2nd quarter. Cloverdale Capital Management LLC now owns 492,237 shares of the medical instruments supplier’s stock valued at $4,785,000 after purchasing an additional 110,495 shares during the period. Finally, Bamco Inc. NY raised its stake in Sientra by 109.3% during the 2nd quarter. Bamco Inc. NY now owns 471,500 shares of the medical instruments supplier’s stock valued at $4,583,000 after purchasing an additional 246,183 shares during the period. 77.61% of the stock is currently owned by institutional investors.

About Sientra

Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.

Analyst Recommendations for Sientra (NASDAQ:SIEN)

Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.